DUSLX | RGAFX | DUSLX / RGAFX | |
Total Expense Ratio | 0.18 | 0.34 | 53% |
Annual Report Gross Expense Ratio | 0.18 | 0.34 | 53% |
Fund Existence | 13 years | 23 years | - |
Gain YTD | 7.662 | 10.642 | 72% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.8B | 323B | 1% |
Annual Yield % from dividends | 0.96 | 0.57 | 169% |
Returns for 1 year | 12.95 | 9.70 | 134% |
Returns for 3 years | 60.16 | 55.29 | 109% |
Returns for 5 years | 80.04 | 46.50 | 172% |
Returns for 10 years | 190.42 | 87.14 | 219% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ERHSX | 14.05 | N/A | N/A |
Eaton Vance Worldwide Health Sci R | |||
GFVUX | 16.02 | N/A | N/A |
Goldman Sachs Focused Value R6 | |||
AIVBX | 19.35 | -0.11 | -0.57% |
American Funds International Vntg A | |||
MALOX | 20.69 | -0.13 | -0.62% |
BlackRock Global Allocation Instl | |||
RDLAX | 11.20 | -0.08 | -0.71% |
Columbia Disciplined Growth A |